- 現金殖利率: 4.73%、總殖利率: 4.73%、5年平均現金配發率: 92.35%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 3.48 | -51.67 | 4.00 | -27.27 | 0.00 | 0 | 114.94 | 50.47 | 0.00 | 0 | 114.94 | 50.47 |
2022 (9) | 7.20 | 51.9 | 5.50 | 37.5 | 0.00 | 0 | 76.39 | -9.48 | 0.00 | 0 | 76.39 | -9.48 |
2021 (8) | 4.74 | 15.89 | 4.00 | 0.0 | 0.00 | 0 | 84.39 | -13.71 | 0.00 | 0 | 84.39 | -13.71 |
2020 (7) | 4.09 | -19.8 | 4.00 | -11.11 | 0.00 | 0 | 97.80 | 10.84 | 0.00 | 0 | 97.80 | 10.84 |
2019 (6) | 5.10 | -8.11 | 4.50 | -10.0 | 0.00 | 0 | 88.24 | -2.06 | 0.00 | 0 | 88.24 | -2.06 |
2018 (5) | 5.55 | 10.34 | 5.00 | 11.11 | 0.00 | 0 | 90.09 | 0.7 | 0.00 | 0 | 90.09 | 0.7 |
2017 (4) | 5.03 | -16.03 | 4.50 | -10.0 | 0.00 | 0 | 89.46 | 7.18 | 0.00 | 0 | 89.46 | 7.18 |
2016 (3) | 5.99 | -13.06 | 5.00 | -16.67 | 0.00 | 0 | 83.47 | -4.15 | 0.00 | 0 | 83.47 | -4.15 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 1.33 | -28.49 | 49.44 | 1.38 | -18.34 | 112.31 | 4.75 | 38.48 | 105.63 |
24Q2 (19) | 1.86 | 19.23 | 75.47 | 1.69 | 44.44 | 113.92 | 3.43 | 119.87 | 141.55 |
24Q1 (18) | 1.56 | 30.0 | 321.62 | 1.17 | -17.02 | 225.0 | 1.56 | -55.56 | 321.62 |
23Q4 (17) | 1.20 | 34.83 | 84.62 | 1.41 | 116.92 | 76.25 | 3.51 | 51.95 | -51.85 |
23Q3 (16) | 0.89 | -16.04 | -59.91 | 0.65 | -17.72 | -63.89 | 2.31 | 62.68 | -65.21 |
23Q2 (15) | 1.06 | 186.49 | -57.43 | 0.79 | 119.44 | -65.95 | 1.42 | 283.78 | -67.8 |
23Q1 (14) | 0.37 | -43.08 | -80.73 | 0.36 | -55.0 | -78.31 | 0.37 | -94.92 | -80.73 |
22Q4 (13) | 0.65 | -70.72 | -62.21 | 0.80 | -55.56 | -53.76 | 7.29 | 9.79 | 52.83 |
22Q3 (12) | 2.22 | -10.84 | 58.57 | 1.80 | -22.41 | 28.57 | 6.64 | 50.57 | 116.99 |
22Q2 (11) | 2.49 | 29.69 | 137.14 | 2.32 | 39.76 | 118.87 | 4.41 | 129.69 | 165.66 |
22Q1 (10) | 1.92 | 11.63 | 220.0 | 1.66 | -4.05 | 186.21 | 1.92 | -59.75 | 220.0 |
21Q4 (9) | 1.72 | 22.86 | 129.33 | 1.73 | 23.57 | 124.68 | 4.77 | 55.88 | 15.78 |
21Q3 (8) | 1.40 | 33.33 | 19.66 | 1.40 | 32.08 | 50.54 | 3.06 | 84.34 | -9.2 |
21Q2 (7) | 1.05 | 75.0 | 36.36 | 1.06 | 82.76 | 27.71 | 1.66 | 176.67 | -24.55 |
21Q1 (6) | 0.60 | -20.0 | -58.04 | 0.58 | -24.68 | -55.73 | 0.60 | -85.44 | -58.04 |
20Q4 (5) | 0.75 | -35.9 | -31.82 | 0.77 | -17.2 | -44.2 | 4.12 | 22.26 | -20.0 |
20Q3 (4) | 1.17 | 51.95 | 0.0 | 0.93 | 12.05 | 0.0 | 3.37 | 53.18 | 0.0 |
20Q2 (3) | 0.77 | -46.15 | 0.0 | 0.83 | -36.64 | 0.0 | 2.20 | 53.85 | 0.0 |
20Q1 (2) | 1.43 | 30.0 | 0.0 | 1.31 | -5.07 | 0.0 | 1.43 | -72.23 | 0.0 |
19Q4 (1) | 1.10 | 0.0 | 0.0 | 1.38 | 0.0 | 0.0 | 5.15 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/11 | 4.63 | 32.04 | 27.37 | 41.3 | 28.77 | 11.67 | N/A | - | ||
2024/10 | 3.51 | -0.78 | 0.06 | 36.67 | 28.95 | 10.72 | N/A | - | ||
2024/9 | 3.53 | -3.81 | 36.77 | 33.17 | 33.01 | 10.97 | 0.68 | - | ||
2024/8 | 3.67 | -2.3 | 28.96 | 29.63 | 32.57 | 10.98 | 0.68 | - | ||
2024/7 | 3.76 | 6.14 | 45.13 | 25.96 | 33.1 | 11.32 | 0.66 | - | ||
2024/6 | 3.54 | -11.78 | 9.29 | 22.2 | 31.26 | 12.06 | 0.61 | - | ||
2024/5 | 4.02 | -10.73 | 14.89 | 18.65 | 36.47 | 12.37 | 0.6 | - | ||
2024/4 | 4.5 | 16.88 | 82.01 | 14.63 | 43.89 | 11.27 | 0.66 | 去年同期營收低,導致基期偏低 | ||
2024/3 | 3.85 | 31.74 | 49.31 | 10.13 | 31.64 | 10.13 | 0.65 | - | ||
2024/2 | 2.92 | -13.03 | 19.84 | 6.28 | 22.74 | 9.09 | 0.73 | - | ||
2024/1 | 3.36 | 19.59 | 25.38 | 3.36 | 25.38 | 9.81 | 0.67 | - | ||
2023/12 | 2.81 | -22.7 | 19.96 | 34.88 | -37.08 | 9.95 | 0.56 | - | ||
2023/11 | 3.64 | 3.73 | 29.36 | 32.07 | -39.59 | 9.72 | 0.57 | - | ||
2023/10 | 3.5 | 35.59 | -23.52 | 28.44 | -43.44 | 8.94 | 0.62 | - | ||
2023/9 | 2.58 | -9.3 | -45.81 | 24.93 | -45.44 | 8.03 | 0.85 | - | ||
2023/8 | 2.85 | 9.94 | -39.68 | 22.35 | -45.4 | 8.68 | 0.79 | - | ||
2023/7 | 2.59 | -20.07 | -44.1 | 19.5 | -46.14 | 9.33 | 0.73 | - | ||
2023/6 | 3.24 | -7.26 | -44.42 | 16.91 | -46.45 | 9.21 | 0.76 | - | ||
2023/5 | 3.5 | 41.4 | -39.26 | 13.67 | -46.91 | 8.55 | 0.82 | - | ||
2023/4 | 2.47 | -4.11 | -49.01 | 10.17 | -49.11 | 7.49 | 0.93 | - | ||
2023/3 | 2.58 | 5.73 | -49.3 | 7.7 | -49.14 | 7.7 | 1.03 | - | ||
2023/2 | 2.44 | -9.01 | -44.46 | 5.12 | -49.06 | 7.46 | 1.06 | - | ||
2023/1 | 2.68 | 14.42 | -52.62 | 2.68 | -52.62 | 7.83 | 1.01 | 去年基期相對偏高 | ||
2022/12 | 2.34 | -16.64 | -51.63 | 55.44 | 6.92 | 9.74 | 0.94 | 去年基期相對偏高 | ||
2022/11 | 2.81 | -38.67 | -53.07 | 53.1 | 12.95 | 12.16 | 0.76 | 去年基期相對偏高 | ||
2022/10 | 4.58 | -3.92 | -20.92 | 50.29 | 22.59 | 14.08 | 0.65 | - | ||
2022/9 | 4.77 | 0.96 | -12.0 | 45.71 | 29.76 | 14.13 | 0.83 | - | ||
2022/8 | 4.72 | 1.89 | -4.58 | 40.94 | 37.35 | 15.2 | 0.78 | - | ||
2022/7 | 4.64 | -20.52 | 16.97 | 36.21 | 45.71 | 16.23 | 0.73 | - | ||
2022/6 | 5.83 | 1.33 | 50.22 | 31.58 | 51.16 | 16.44 | 0.71 | 去年疫情基期低,今年恢復正常 | ||
2022/5 | 5.76 | 18.71 | 51.55 | 25.74 | 51.38 | 15.69 | 0.74 | 去年疫情基期低,今年恢復正常 | ||
2022/4 | 4.85 | -4.66 | 19.55 | 19.99 | 51.33 | 14.33 | 0.81 | 去年疫情基期低,今年恢復正常 | ||
2022/3 | 5.09 | 15.83 | 65.97 | 15.14 | 65.42 | 15.14 | 0.87 | 去年疫情導致基期低,今年恢復正常 | ||
2022/2 | 4.39 | -22.38 | 67.11 | 10.05 | 65.14 | 14.89 | 0.88 | 去年疫情導致基期低,今年恢復正常 | ||
2022/1 | 5.66 | 16.82 | 63.64 | 5.66 | 63.64 | 16.49 | 0.79 | 去年疫情導致基期低,今年恢復正常 | ||
2021/12 | 4.84 | -19.12 | 66.78 | 51.85 | 16.96 | 16.63 | 0.86 | 去年疫情導致基期低,今年恢復正常 | ||
2021/11 | 5.99 | 3.33 | 71.12 | 47.01 | 13.47 | 17.2 | 0.83 | 去年疫情導致基期低,今年恢復正常 | ||
2021/10 | 5.8 | 6.9 | 50.58 | 41.02 | 8.15 | 16.17 | 0.88 | 去年疫情導致基期低,今年恢復正常 | ||
2021/9 | 5.42 | 9.48 | 31.86 | 35.22 | 3.36 | 14.34 | 1.07 | - | ||
2021/8 | 4.95 | 24.9 | 22.98 | 29.8 | -0.54 | 12.8 | 1.2 | - | ||
2021/7 | 3.96 | 2.06 | 2.59 | 24.85 | -4.19 | 11.65 | 1.32 | - | ||
2021/6 | 3.88 | 2.23 | 16.74 | 20.89 | -5.38 | 11.74 | 1.0 | - | ||
2021/5 | 3.8 | -6.35 | 24.11 | 17.0 | -9.31 | 10.92 | 1.08 | - | ||
2021/4 | 4.06 | 32.35 | 29.95 | 13.21 | -15.83 | 9.75 | 1.21 | - | ||
2021/3 | 3.06 | 16.62 | -25.39 | 9.15 | -27.2 | 9.15 | 0.92 | - | ||
2021/2 | 2.63 | -23.99 | -31.54 | 6.09 | -28.08 | 8.99 | 0.94 | - | ||
2021/1 | 3.46 | 19.06 | -25.21 | 3.46 | -25.21 | 9.86 | 0.86 | - | ||
2020/12 | 2.9 | -17.02 | -33.22 | 44.33 | -16.83 | 10.25 | 0.64 | - | ||
2020/11 | 3.5 | -9.06 | -4.19 | 41.43 | -15.38 | 11.46 | 0.57 | - | ||
2020/10 | 3.85 | -6.38 | -17.22 | 37.93 | -16.28 | 11.98 | 0.55 | - | ||
2020/9 | 4.11 | 2.1 | 2.71 | 34.08 | -16.17 | 12.0 | 0.69 | - | ||
2020/8 | 4.03 | 4.2 | -2.17 | 29.97 | -18.23 | 11.22 | 0.74 | - | ||
2020/7 | 3.86 | 16.14 | -8.71 | 25.94 | -20.26 | 10.25 | 0.81 | - | ||
2020/6 | 3.33 | 8.68 | -28.7 | 22.08 | -21.99 | 9.51 | 0.91 | - | ||
2020/5 | 3.06 | -1.95 | -33.5 | 18.75 | -20.67 | 10.29 | 0.84 | - | ||
2020/4 | 3.12 | -24.0 | -33.53 | 15.69 | -17.57 | 11.07 | 0.78 | - | ||
2020/3 | 4.11 | 7.0 | -20.79 | 12.57 | -12.34 | 12.57 | 0.71 | - | ||
2020/2 | 3.84 | -16.96 | 7.18 | 8.46 | -7.55 | 12.81 | 0.7 | - | ||
2020/1 | 4.62 | 6.3 | -17.02 | 4.62 | -17.02 | 0.0 | N/A | - | ||
2019/12 | 4.35 | 19.05 | 33.9 | 53.3 | -18.86 | 0.0 | N/A | - |